# Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients

> **NCT00799201** · PHASE4 · TERMINATED · sponsor: **CAMC Health System** · enrollment: 3 (actual)

## Conditions studied

- Constipation
- Analgesia

## Interventions

- **DRUG:** Naloxone and Docusate

## Key facts

- **NCT ID:** NCT00799201
- **Lead sponsor:** CAMC Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-08
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Naloxone became unavailable due to manufacturing shortatges requiring the study to be terminated.
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799201, "Enteral Naloxone Versus a Traditional Bowel Regimen for the Prevention of Opioid Induced Constipation in Trauma Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00799201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*